Ronald W. Walenga
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Pharmacology top 5%
- Physiology top 10%
- Biochemistry top 2%
- Co-authors
- Maurice B. FeinsteinMarie J. StuartMichael W. KonstanPamela B. DavisYamaja SettyEvan E. OpasTracey L. BonfieldAnna van Heeckeren
- Topics
- Eicosanoids and Hypertension Pharmacology (12 papers)Inflammatory mediators and NSAID effects (10 papers)Peroxisome Proliferator-Activated Receptors (5 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationAmerican Journal of Respiratory and Critical Care Medicine
- Partner nations
- United StatesCanada
In The Last Decade
Ronald W. Walenga
47 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 501
- Pulmonary and Respiratory Medicine 430
- Pharmacology 278
- Physiology 254
- Biochemistry 225
Countries citing papers authored by Ronald W. Walenga
This map shows the geographic impact of Ronald W. Walenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald W. Walenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald W. Walenga more than expected).
Fields of papers citing papers by Ronald W. Walenga
This network shows the impact of papers produced by Ronald W. Walenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald W. Walenga. The network helps show where Ronald W. Walenga may publish in the future.
Co-authorship network of co-authors of Ronald W. Walenga
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald W. Walenga. A scholar is included among the top collaborators of Ronald W. Walenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald W. Walenga. Ronald W. Walenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 29 | |
| 3 | 99 | |
| 4 | 43 | |
| 5 | 130 | |
| 6 | 27 | |
| 7 | 8 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | 33 | |
| 12 | 3 | |
| 13 | 14 | |
| 14 | 34 | |
| 15 | 18 | |
| 16 | 20 | |
| 17 | Neutral glycosphingolipids of Spirometra life-cycle stages. | 3 |
| 18 | 10 | |
| 19 | 19 | |
| 20 | 0 |
About Ronald W. Walenga
Ronald W. Walenga is a scholar working on Biochemistry, Pharmacology and Hematology, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory mediators and NSAID effects (10 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Biochemistry (225 citations), Pharmacology (278 citations) and Pulmonary and Respiratory Medicine (430 citations). Ronald W. Walenga has collaborated with scholars based in United States and Canada. Frequent co-authors include Maurice B. Feinstein, Marie J. Stuart, Michael W. Konstan, Pamela B. Davis, Yamaja Setty, Evan E. Opas, Tracey L. Bonfield, Anna van Heeckeren, Kathleen A. Hilliard and Jay B. Hilliard. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.